Detalhe da pesquisa
1.
Extended therapy with letrozole as adjuvant treatment of postmenopausal patients with early-stage breast cancer: a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 22(10): 1458-1467, 2021 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34543613
2.
Netupitant/palonosetron (NEPA) and dexamethasone for prevention of emesis in breast cancer patients receiving adjuvant anthracycline plus cyclophosphamide: a multi-cycle, phase II study.
BMC Cancer
; 20(1): 232, 2020 Mar 19.
Artigo
Inglês
| MEDLINE | ID: mdl-32188417
3.
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial.
BMC Med
; 17(1): 207, 2019 11 21.
Artigo
Inglês
| MEDLINE | ID: mdl-31747948
4.
Randomized phase III trial of adjuvant epirubicin followed by cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) versus CMF followed by epirubicin in patients with node-negative or 1-3 node-positive rapidly proliferating breast cancer.
Breast Cancer Res Treat
; 125(3): 775-84, 2011 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-21132360
5.
The impact of progesterone receptor expression on prognosis of patients with rapidly proliferating, hormone receptor-positive early breast cancer: a post hoc analysis of the IBIS 3 trial.
Ther Adv Med Oncol
; 12: 1758835919888999, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32158505
6.
Time to initiation of adjuvant chemotherapy in patients with rapidly proliferating early breast cancer.
Eur J Cancer
; 51(14): 1874-81, 2015 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-26206258
7.
The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast Cancer.
PLoS One
; 10(9): e0136731, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-26340098
8.
Temozolomide and interferon-alpha in metastatic melanoma: a phase II study of the Italian Melanoma Intergroup.
Melanoma Res
; 14(4): 295-9, 2004 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-15305161
9.
Correction: The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast Cancer.
PLoS One
; 10(9): e0139650, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-26406908